Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
China · Delayed Price · Currency is CNY 18.95
-1.45 (-7.11%)
At close: Sep 30, 2026
SHA:688203 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,799 | 2,571 | 1,974 | 2,639 | 3,172 | - | |
Market Cap Growth | 28.62% | 30.25% | -25.19% | -16.80% | - | - |
Enterprise Value | 3,716 | 2,366 | 1,646 | 2,057 | 3,280 | - |
Last Close Price | 18.95 | 12.78 | 9.68 | 12.84 | 15.37 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 156.17 | 260.64 | 55.60 | 60.60 | 67.44 | - |
Forward PE | - | 28.59 | 30.44 | 24.51 | 37.94 | - |
PS Ratio | 3.62 | 3.02 | 2.34 | 3.50 | 5.24 | - |
PB Ratio | 2.54 | 1.74 | 1.32 | 1.78 | 2.19 | - |
P/TBV Ratio | 2.67 | 1.83 | 1.39 | 1.88 | 2.31 | - |
P/OCF Ratio | 130.49 | 123.36 | 50.83 | 16.19 | 23.30 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.54 | 2.78 | 1.95 | 2.73 | 5.42 | - |
EV/EBITDA Ratio | 30.13 | 27.43 | 16.06 | 22.93 | 48.03 | - |
EV/EBIT Ratio | 92.60 | 138.98 | 44.53 | 56.97 | 124.11 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.14 | 0.13 | 0.17 | 0.19 | 0.59 |
Debt / EBITDA Ratio | 1.50 | 2.36 | 1.94 | 2.84 | 3.93 | 4.69 |
Net Debt / Equity Ratio | -0.05 | -0.08 | -0.21 | -0.40 | -0.46 | 0.15 |
Net Debt / EBITDA Ratio | -0.68 | -1.43 | -3.09 | -6.66 | -9.75 | 1.17 |
Net Debt / FCF Ratio | 1.52 | 1.16 | 1.24 | 11.71 | 7.47 | -0.40 |
Asset Turnover | 0.52 | 0.41 | 0.41 | 0.38 | 0.39 | 0.50 |
Inventory Turnover | 4.47 | 4.31 | 4.85 | 4.65 | 4.09 | 5.13 |
Quick Ratio | 0.86 | 0.84 | 1.22 | 2.03 | 3.10 | 0.82 |
Current Ratio | 1.52 | 1.40 | 1.68 | 2.43 | 3.59 | 1.25 |
Return on Equity (ROE) | 1.86% | 0.66% | 2.39% | 2.97% | 4.46% | 5.54% |
Return on Assets (ROA) | 1.24% | 0.52% | 1.12% | 1.13% | 1.06% | 2.40% |
Return on Invested Capital (ROIC) | 2.02% | 0.75% | 2.70% | 3.53% | 3.08% | 7.84% |
Return on Capital Employed (ROCE) | 2.60% | 1.10% | 2.30% | 2.20% | 1.60% | 5.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.73% | 0.38% | 1.80% | 1.65% | 1.48% | - |
FCF Yield | -1.43% | -4.13% | -12.88% | -1.94% | -2.81% | - |
Dividend Yield | - | - | 0.62% | 0.62% | 0.46% | - |
Payout Ratio | 18.12% | 184.00% | 66.44% | 53.56% | 33.65% | 40.94% |
Buyback Yield / Dilution | -28.89% | -2.02% | 4.88% | -23.45% | -9.53% | -66.61% |
Total Shareholder Return | -28.89% | -2.02% | 5.50% | -22.83% | -9.07% | -66.61% |